Trial Profile
Phase III trial comparing the effects of trospium chloride extended-release versus placebo in patients with overactive bladder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2011
Price :
$35
*
At a glance
- Drugs Trospium chloride (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals Solutions
- 05 Nov 2010 New trial record.